Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).

Saved in:
Bibliographic Details
Title: Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).
Authors: Ross MM; Evidera Inc., Wilmington, NC, USA., Chung Y; AstraZeneca, Wilmington, DE, USA., Carr T; Asthma and Airways Disease Research Center, University of AZ, Tucson, AZ, USA., Ambrose CS; AstraZeneca, Wilmington, DE, USA., Lindsley AW; Amgen, Thousand Oaks, CA, USA., Collacott H; Evidera Inc., Wilmington, NC, USA., Schulz A; Evidera Inc., Wilmington, NC, USA., Desai P; Novartis, East Hanover, NJ, USA., Rane P; Amgen, Thousand Oaks, CA, USA., Williams M; Northern VA Pulmonary and Critical Care Associates PC, Annadale, VA, USA., Gelhorn HL; Evidera Inc., Wilmington, NC, USA.
Source: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Dec; Vol. 61 (12), pp. 1746-1758. Date of Electronic Publication: 2024 Aug 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1532-4303
DOI:10.1080/02770903.2024.2380520